D75.838
Other thrombocytosis
Clinical Classification Guidelines
Inclusion Terms
- Reactive thrombocytosis
- Secondary thrombocytosis
Code Also
- underlying condition, if known and applicable
Medical Intelligence & Overview
Other thrombocytosis, classified under ICD-10 code D75.838, refers to an elevated platelet count in the blood that does not fall under the more common types of thrombocytosis. This condition is often considered reactive or secondary, meaning it occurs due to another underlying health issue. Recognizing the causes and symptoms associated with this condition helps in understanding its implications and the importance of addressing its root causes.
Causes & Symptoms
Clinical Causes: Infections such as bacterial, viral, or parasitic illnesses Inflammatory diseases like rheumatoid arthritis or inflammatory bowel disease Iron deficiency anemia Certain cancers, including lymphomas or other malignancies Recovery phase after significant blood loss or hemolytic anemia Splenectomy (surgical removal of the spleen) Medication reactions or side effects
Key Symptoms: Often no specific symptoms, especially if the increase in platelets is mild Headaches and dizziness Strengthening of blood clots leading to an increased risk of thrombosis Pain or swelling in limbs due to blood clots Unusual bleeding or bruising in some cases Signs of underlying disorders such as fever, fatigue, or weight loss, if related to infections or malignancies
Diagnostic & Treatment
Diagnosis Path: Diagnosis of other thrombocytosis typically involves blood tests, including a complete blood count (CBC) to measure platelet levels. Additional tests may include:
Treatment Protocols: Managing other thrombocytosis involves addressing the underlying condition responsible for the elevated platelet count. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D75.838 a billable ICD-10 code?
Yes, D75.838 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D75.838?
Clinical documentation must specify the nature of Other thrombocytosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference